The cost effectiveness of infliximab in the treatment of ankylosing spondylitis in Spain. Comparison of clinical trial and clinical practice data

被引：0
|
作者：
Kobelt, G.
Andlin-Sobocki, P.
Collantes-Estevez, E.
Gratacos-Masmitja, J.
Pocovi, A.
Mulero-Mendoza, J.
机构：
[1] European Hlth Econ, Stockholm, Sweden
[2] Stockholm Hlth Econ, Stockholm, Sweden
[3] Hosp Reina Sofia, Cordoba, Spain
[4] Hosp Sabadell, Barcelona, Spain
[5] Schering Plough Corp, Madrid, Spain
[6] Clin Puerta Hierro, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：282 / 283
页数：2
相关论文
共 50 条
  • [41] Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
    Paul Emery
    Marjolijn Van Keep
    Steve Beard
    Chris Graham
    LaStella Miles
    Steffen Marc Jugl
    Praveen Gunda
    Anna Halliday
    Helena Marzo-Ortega
    PharmacoEconomics, 2018, 36 : 1015 - 1027
  • [42] Cost effectiveness of adalimumab for the treatment of ankylosing spondylitis in the United Kingdom
    Botteman, M. F.
    Hay, J. W.
    Luo, M. P.
    Curry, A. S.
    Wong, R. L.
    van Hout, B. A.
    RHEUMATOLOGY, 2007, 46 (08) : 1320 - 1328
  • [43] Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
    Emery, Paul
    Van Keep, Marjolijn
    Beard, Steve
    Graham, Chris
    Miles, LaStella
    Jugl, Steffen Marc
    Gunda, Praveen
    Halliday, Anna
    Marzo-Ortega, Helena
    PHARMACOECONOMICS, 2018, 36 (08) : 1015 - 1027
  • [44] Clinical investigation of methotrexate in the treatment of ankylosing spondylitis
    Altan, L
    Bingöl, Ü
    Karakoç, Y
    Aydiner, S
    Yurtkuran, M
    Yurtkuran, M
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2001, 30 (05) : 255 - 259
  • [45] COST-EFFECTIVENESS OF SECUKINUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS IN BRAZIL
    Libanore, A.
    Huerta, C.
    Tozato, C.
    VALUE IN HEALTH, 2020, 23 : S221 - S221
  • [46] Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece
    George Gourzoulidis
    Argyro Solakidi
    Marina Psarra
    Eleni Nikitopoulou
    Charalampos Tzanetakos
    Clinical Drug Investigation, 2024, 44 : 59 - 69
  • [47] Bayesian cost-effectiveness analysis of treatment of ankylosing spondylitis
    Jansen, J. P.
    Gaugris, S.
    Stam, W.
    VALUE IN HEALTH, 2008, 11 (03) : A263 - A263
  • [48] Real-Life Effectiveness of Infliximab in the Treatment of Ankylosing Spondylitis: The Canadian Experience
    Rahinan, Proton
    Sampalis, John
    Khalil, Hayssam
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1276 - 1276
  • [49] Clinical effectiveness of benralizumab in clinical practice in Spain
    Ausin Herrero, P.
    Levy, A.
    Padilla Galo, A.
    Moya Carmona, I
    Luzon Alonso, E.
    Sanchez Tena, J.
    Resler, G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [50] Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study
    de Miguel, Eugenio
    Fernandez-Carballido, Cristina
    Gratacos, Jordi
    Pablos, Jose L.
    Juanola, Xavier
    Ariza, Rafael
    Terradas-Montana, Pau
    Sanabra, Cristina
    Sastre, Carlos
    REUMATOLOGIA CLINICA, 2023, 19 (02): : 99 - 105
12345